Literature DB >> 9140967

YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.

A Holmström1, J Petterson, R Rosqvist, S Håkansson, F Tafazoli, M Fällman, K E Magnusson, H Wolf-Watz, A Forsberg.   

Abstract

Introduction of anti-host factors into eukaryotic cells by extracellular bacteria is a strategy evolved by several Gram-negative pathogens. In these pathogens, the transport of virulence proteins across the bacterial membranes is governed by closely related type III secretion systems. For pathogenic Yersinia, the protein transport across the eukaryotic cell membrane occurs by a polarized mechanism requiring two secreted proteins, YopB and YopD. YopB was recently shown to induce the formation of a pore in the eukaryotic cell membrane, and through this pore, translocation of Yop effectors is believed to occur (Håkansson et al., 1996b). We have previously shown that YopK of Yersinia pseudotuberculosis is required for the development of a systemic infection in mice. Here, we have analysed the role of YopK in the virulence process in more detail. A yopK-mutant strain was found to induce a more rapid YopE-mediated cytotoxic response in HeLa cells as well as in MDCK-1 cells compared to the wild-type strain. We found that this was the result of a cell-contact-dependent increase in translocation of YopE into HeLa cells. In contrast, overexpression of YopK resulted in impaired translocation. In addition, we found that YopK also influenced the YopB-dependent lytic effect on sheep erythrocytes as well as on HeLa cells. A yopK-mutant strain showed a higher lytic activity and the induced pore was larger compared to the corresponding wild-type strain, whereas a strain overexpressing YopK reduced the lytic activity and the apparent pore size was smaller. The secreted YopK protein was found not to be translocated but, similar to YopB, localized to cell-associated bacteria during infection of HeLa cells. Based on these results, we propose a model where YopK controls the translocation of Yop effectors into eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140967     DOI: 10.1046/j.1365-2958.1997.3211681.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  59 in total

1.  Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria.

Authors:  F Tafazoli; A Holmström; A Forsberg; K E Magnusson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains.

Authors:  Jan Olsson; Petra J Edqvist; Jeanette E Bröms; Ake Forsberg; Hans Wolf-Watz; Matthew S Francis
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 3.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.

Authors:  K L DeBord; V T Lee; O Schneewind
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

5.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag.

Authors:  Julie Torruellas Garcia; Franco Ferracci; Michael W Jackson; Sabrina S Joseph; Isabelle Pattis; Lisa R W Plano; Wolfgang Fischer; Gregory V Plano
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

8.  Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.

Authors:  Sara E Thorslund; David Ermert; Anna Fahlgren; Saskia F Erttmann; Kristina Nilsson; Ava Hosseinzadeh; Constantin F Urban; Maria Fällman
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

9.  Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin.

Authors:  V Finck-Barbançon; T L Yahr; D W Frank
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

10.  Yersinia pseudotuberculosis Blocks Neutrophil Degranulation.

Authors:  Nayyer Taheri; Anna Fahlgren; Maria Fällman
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.